| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10818305 | Clinical Biochemistry | 2005 | 7 Pages |
Abstract
HER2/neu can be measured reliably by the EIA method as confirmed by WB. The quantitative assessment of HER2/neu expression in malignant tumors aided by other proliferation markers such as SPF, DI, and ploidy could be useful in selecting patients for more aggressive treatment or for predicting outcome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Sanaa Eissa, Heba S. Ali, A.H. Al Tonsi, A. Zaglol, Omar El Ahmady,